Excaliard Pharmaceuticals, Inc.;Ionis Pharmaceuticals, Inc.
发明人:
Nicholas M. Dean,J. Gordon Foulkes,Niall O'Donnell,C. Frank Bennett,Susan M. Freier,Niall ODonnell
申请号：
US14753860
公开号：
US09688987B2
申请日:
2015.06.29
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This invention provides compounds which comprise modified oligonucleotides capable of inhibitory expression of connective tissue factor and composition containing same as well as methods of treating hyperprolific disorders and fibrotic diseases, and of reducing scarring resulting from wound healing using such compounds.
